LEGIONELLA - World Health Organization
LEGIONELLA - World Health Organization
LEGIONELLA - World Health Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
11.1.2 Staining<br />
Legionellae are Gram-negative bacteria with a thin cell wall, but stain poorly in the Gram<br />
procedure if neutral red or safranin is used as the counterstain. This characteristic is probably<br />
due to the composition of legionellae cell walls, which have large amounts of branched-chain<br />
cellular fatty acids and ubiquinones with side chains of 9–14 isoprene units (Moss et al., 1977;<br />
Lambert & Moss, 1989). Fatty acid and ubiquinone profiling have been used for identifying<br />
Legionella isolates to the level of species (Benson & Fields, 1998). On its own, Gram staining is<br />
inconclusive, even when samples are taken from normally sterile sites, such as transtracheal aspirates,<br />
lung biopsies or pleural fluids. Legionellae from these tissues appear as small, Gram-negative<br />
rods of varying sizes when counterstained with basic fuchsin. This effect is emphasized in legionellaeinfected<br />
tissues (Yu, 2000). Dieterle’s silver impregnation method is an alternative means of staining<br />
legionellae (Dieterle, 1927; Thomason et al., 1979). More sensitive and specific methods of<br />
identifying legionellae include antibody-coupled fluorescent dyes and immunoperoxidase staining.<br />
Further information on identifying legionellae species is given in Section 11.4.<br />
11.2 Diagnostic methods<br />
The clinical symptoms of infection with Legionella are indistinguishable from the symptoms<br />
of other causes of pneumonia. Accurate diagnostic methods are therefore needed to identify<br />
Legionella, and to provide timely and appropriate therapy. To improve diagnosis, specialized<br />
laboratory tests must be carried out, by the clinical microbiology laboratory, on patients in a<br />
high-risk category.<br />
Tests for Legionnaires’ disease should ideally be performed on all patients with pneumonia at risk,<br />
including those who are seriously ill (with or without clinical features of legionellosis), and those for<br />
whom no alternative diagnosis prevails. In particular, tests for Legionnaires’ disease should be carried<br />
out on ill patients who are older than 40 years, immunosuppressed or unresponsive to beta-lactam<br />
antibiotics, or who might have been exposed to Legionella during an outbreak (Bartlett et al., 1998).<br />
Despite the availability of immunological and molecular genetic methods, diagnosis of<br />
Legionnaires’ disease is generally effective only for L. pneumophila serogroup 1. The sensitivity and<br />
specificity of methods for diagnosing and identifying other L. pneumophila serogroups and<br />
species of Legionella are far from perfect (Tartakovsky, 2001).<br />
Since 1995, diagnostic tests for legionellosis have changed significantly. The following laboratory<br />
methods are currently used for diagnosing Legionella infections (Stout, Rihs & Yu, 2003):<br />
• isolation of the bacterium on culture media<br />
• identification of the bacterium using paired serology<br />
• detection of antigens in urine<br />
<strong>LEGIONELLA</strong> AND THE PREVENTION OF LEGIONELLOSIS